Abstract:Even during extended periods of effective immunological control, a substantial dynamic of the viral genome can be observed in different cellular compartments in HIV-1 positive individuals, indicating the persistence of active viral reservoirs. To obtain further insights, we studied changes in the proviral as well as in the viral HIV-1 envelope (Env) sequence along with transcriptional, translational and viral outgrowth activity as indicators for viral dynamics and genomic intactness. Our study identified distinct reservoir patterns that either represented highly sequence-diverse HIV-1 populations or only a single / few persisting virus variants. The single dominating variants were more often found in individuals starting ART during early infection phases, indicating that early treatment might limit reservoir diversification. At the same time, more sequence-diverse HIV reservoirs correlated with a poorer immune status, indicated by lower CD4 count, a higher number of regimen changes and more co-morbidities. Furthermore, we noted that in T-cell populations in the peripheral blood, replication-competent HIV-1 is predominantly present in Lymph node homing TN (naïve) and TCM (central memory) T cells. Provirus genomes archived in TTM (transitional memory) and TEM (effector memory) T cells more frequently tended to carry inactivating mutations and, population-wise, possess changes in the genetic diversity. These discriminating properties of the viral reservoir in T-cell subsets may have important implications for new early therapy strategies, underscoring the critical role of early therapy in preserving robust immune surveillance and constraining the viral reservoir. Our study demonstrates that a poor immune status associates with and may form a basis for HIV reservoir diversification. Reservoirs for replication-competent, infectious viruses are mainly found in TN and TCM, which harbor a small number of intact viral variants. A distinct population of archived HIV sequences, residing in TTM and TEM, is characterized by a shifted genetic diversity. While the former cells are likely to harbor a promptly re-activatable latent reservoir, the latter with often defective but more variable viral genomes could thus represent a source for retroviral recombination and reactivation.

HIV Tissue Reservoirs: Current Advances in Research

Research progress on HIV latency-reversing agents and its mechanism

Eliminating the HIV tissue reservoir: current strategies and challenges

The multifaceted nature of HIV tissue reservoirs

Insights into the HIV-1 Latent Reservoir and Strategies to Cure HIV-1 Infection

The Hidden Enemy Within: Uncovering the Secrets of HIV Tissues Reservoirs and Current mRNA Vaccine Development

Research progress on human immunodeficiency virus reservoir and its eradication

Nonnegligible contribution of non-lymphoid tissue to viral reservoir during the short-term early cART in SIVmac239-infected Chinese rhesus macaques

The reservoir of latent HIV

Reservoir of Human Immunodeficiency Virus in the Brain: New Insights into the Role of T Cells

Targeting HIV persistence in the tissue

HIV-1 diversity in viral reservoirs obtained from circulating T-cell subsets during early ART and beyond

Research Progress on Human Immunodeficiency Virus Type 1 Latent Infection Activator

HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies

Immune targeting of HIV-1 reservoir cells: a path to elimination strategies and cure

The neglected brain reservoirs：a barrier to an HIV cure

HIV Reservoirs and Treatment Strategies toward Curing HIV Infection

Moving Toward a Functional Cure for HIV-1

Research progress on measuring the latent reservoir of human immunodeficiency virus

[Research advances in evaluation and measurement techniques of latent human immunodeficiency virus reservoirs]

Humanized Mice for Studies of HIV-1 Persistence and Elimination.